JAA
JNJ icon

Joel Adams & Associates’s Johnson & Johnson JNJ Stock Holding History

Joel Adams & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$563K Hold
2,305
– – 0.42% 35
2025
Q4 		$477K Hold
2,305
– – 0.36% 42
2025
Q3 		$427K Hold
2,305
– – 0.34% 41
2025
Q2 		$352K Hold
2,305
– – 0.31% 41
2025
Q1 		$382K Hold
2,305
– – 0.34% 38
2024
Q4 		$333K Buy
+2,305
New +$357K 0.3% 41

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Joel Adams & Associates's JNJ Position: Q1 2026 in Review

Joel Adams & Associates held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,305 shares worth $563K. The position accounts for 0.42% of the portfolio, ranked #35.

Joel Adams & Associates first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Joel Adams & Associates held 2,305 shares of Johnson & Johnson worth $563K as of Q1 2026.
  • Joel Adams & Associates left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.42% of Joel Adams & Associates's portfolio in Q1 2026, its #35 holding.
  • Joel Adams & Associates first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Joel Adams & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.